CCL4L1 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9,
Homozygous: 7 bp deletion in exon 1.
Images
Key facts
- Cell type
- THP-1
- Species or organism
- Human
- Tissue
- Blood
- Knockout validation
- Sanger Sequencing, Western blot
- Mutation description
- Knockout achieved by using CRISPR/Cas9, Homozygous: 7 bp deletion in exon 1
Alternative names
ACT-2, AT744.1, AT744.2, C C motif chemokine 4, C C motif chemokine 4 like, C C motif chemokine ligand 4 like 1, C C motif chemokine ligand 4 like 2, CC chemokine ligand 4, CC chemokine ligand 4L1, CC chemokine ligand 4L1d2, CC chemokine ligand 4L2, CCL4L, CCL4_HUMAN, Chemokine (C C motif) ligand 4, Chemokine (C C motif) ligand 4 like 1, Chemokine (C C motif) ligand 4 like 1, telomeric, Chemokine (C C motif) ligand 4 like 2, Chemokine CC Motif Ligand 4, G 26, G-26 T-lymphocyte-secreted protein, HC21, Immune activation 2, LAG-1, Lymphocyte activation gene 1, Lymphocyte activation gene 1 protein, MGC104418, MGC126025, MGC126026, MIP-1-beta, MIP-1-beta(1-69), MIP-1-beta(3-69), MIP1B, MIP1B1, Macrophage inflammatory protein 1-beta, Macrophage inflammatory protein 1b2, Monocyte adherence induced protein 5 alpha, PAT 744, Protein H400, SCYA2, SCYA4, SCYA4L, SCYA4L1, SCYA4L2, SCYQ4L2, SIS-gamma, Secreted protein G 26, Small inducible cytokine A4 (homologous to mouse Mip 1b), Small-inducible cytokine A4, T-cell activation protein 2, ccl4l 1, small inducible cytokine A4-like
What's included?
Recommended products
CCL4L1 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9,
Homozygous: 7 bp deletion in exon 1.
Key facts
- Cell type
- THP-1
- Species or organism
- Human
- Tissue
- Blood
- Knockout validation
- Sanger Sequencing, Western blot
- Mutation description
- Knockout achieved by using CRISPR/Cas9, Homozygous: 7 bp deletion in exon 1
- Disease
- Acute Monocytic Leukemia
- Concentration
Properties
- Gene name
- CCL4L1
- Gene editing type
- Knockout
- Gene editing method
- CRISPR technology
- Knockout validation
- Sanger Sequencing, Western blot
- Zygosity
- Homozygous
Quality control
- STR analysis
- CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
- Biosafety level
- EU: 1 US: 1
- Adherent/suspension
- Suspension
- Gender
- Male
Storage
- Shipped at conditions
- Ambient - Can Ship with Ice
- Appropriate short-term storage conditions
- -20°C
- Appropriate long-term storage conditions
- -20°C
Notes
Knockout cell lysate achieved by CRISPR/Cas9.
Treatments:
Human CCL4 knockout THP-1 cell lysate - Brefeldin A (5 μg/ml, 6h)
Human wild-type THP-1 cell lysate - Brefeldin A (5 μg/ml, 6h)
Human CCL4 knockout THP-1 cell lysate - PMA (100 ng/ml, 56h), LPS (1 μg/ml, 24h) and Brefeldin A (5 μg/ml, during the last 6h of LPS treatment)
Human wild-type THP-1 cell lysate - PMA (100 ng/ml, 56h), LPS (1 μg/ml, 24h) and Brefeldin A (5 μg/ml, during the last 6h of LPS treatment)
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
Supplementary info
- This supplementary information is collated from multiple sources and compiled automatically.
- Activity summary
CCL4 also known as MIP-1 beta or MIP-1b has a mechanical role as a chemokine involved in immune response regulation. The protein has a mass of about 7.8 kDa. It expresses in various tissues including leukocytes where it mainly functions as a chemoattractant. MIP-1 beta helps recruit immune cells like natural killer cells and monocytes to sites of inflammation or injury. Researchers frequently measure its levels using assays like MIP-1 beta ELISA or CCL4 ELISA.
- Biological function summary
CCL4 is critical in immune system modulation. It coordinates leukocyte activation and trafficking contributing to inflammation and immune surveillance. It does not function in isolation but rather interacts with other chemokines and receptors. CCL4 alongside its sibling chemokines forms a dynamic network that ensures a balanced immune response. It connects to receptors such as CCR5 playing substantial roles in its activities.
- Pathways
CCL4 participates in essential signaling cascades that mediate immune responses. It is notably part of the chemokine signaling pathway which is instrumental in directing cell movement. CCL4 also engages with proteins like CCR5 in the inflammatory and immune response pathways. This interaction enhances communication between cells required for effective pathogen defense.
- Associated diseases and disorders
CCL4 plays roles in immune-related conditions. It is strongly linked to inflammatory diseases such as rheumatoid arthritis and HIV infection. In rheumatoid arthritis CCL4 levels are often elevated correlating with inflammation severity. During HIV infection CCL4 interacts with proteins like CCR5 a co-receptor the virus uses to enter host cells. This involvement makes MIP-1 beta a target for studies seeking therapeutic interventions in these diseases.
Product promise
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2 product images
Western blot - Human CCL4 knockout THP-1 cell lysate (ab275512)
Lane 1: Wild-type THP-1 Vehicle control + Brefeldin A (5 μ/mL, 6 h) cell lysate 20 μg
Lane 2: Wild-type THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 μ/mL, 24 h) + Brefeldin A (5 μ/mL, 6 h) cell lysate 20 μg
Lane 3: CCL4 knockout THP-1 Vehicle control + Brefeldin A (5 μ/mL, 6 h) cell lysate 20 μg
Lane 4: CCL4 knockout THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 μ/mL, 24 h) + Brefeldin A (5 μ/mL, 6 h) cell lysate 20 μg
False colour image of Western blot: Anti-CCL4/MIP-1 beta antibody [EP521Y] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, Anti-CCL4/MIP-1 beta antibody [EP521Y] ab45690 was shown to bind specifically to CCL4/MIP-1 beta. A band was observed at 12 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CCL4 knockout cell line Human CCL4 knockout THP-1 cell line ab273719 (knockout cell lysate ab275512). To generate this image, wild-type and CCL4 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) at 1/20000 dilution.All lanes: Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (Anti-CCL4/MIP-1 beta antibody [EP521Y] ab45690) at 1/1000 dilution
Lane 1: Wild-type THP-1 Vehicle control + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 2: Wild-type THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 u/mL, 24 h) + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 2: Western blot - Human CCL4 knockout THP-1 cell line (Human CCL4 knockout THP-1 cell line ab273719)
Lane 3: CCL4 knockout THP-1 Vehicle control + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Lane 4: CCL4 knockout THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 u/mL, 24 h) + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 10 kDa
Observed band size: 12 kDa
Next Generation Sequencing - Human CCL4 knockout THP-1 cell lysate (ab275512)
Allele-1: 7 bp deletion in exon 1
Downloads
Product protocols
- Visit the general protocols
- Visit troubleshooting
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com